Acute kidney injury
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who are about to receive intravenous cisplatin for the first time as a cancer chemotherapy regimen; (2) Age = 18 years old, no gender limit; (3) The patient understands and is willing to sign a written consent document; (4) The patient may be receiving combined treatment with cisplatin and other chemotherapy drugs.
Exclusion criteria
Exclusion criteria: (1) Previously received cisplatin therapy; (2) Patients who have previously received dialysis or other renal replacement therapy; (3) Individuals who do not agree to donate peripheral blood or have obvious discomfort in blood sampling; (4) Kidney diseases that do not meet hemodialysis standards, such as chronic kidney disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum creatinine;kidney injury molecule-1;neutropil gelatinase-associated lipocalin; | — |
Countries
China